Friday, November 6, 2015

Cytokines and the Control of Hematopoiesis

Hematopoietic growth factor cytokines are specific glycoproteins that regulate and control hematopoiesis.

Functions of hematopoietic growth factor cytokines:- 

  • Promote cell survival (suppress apoptosis). 
  • Promote proliferation. 
  • Control & regulate the processes of differentiation.

Characteristics of Growth Factors:-

  • Produced by stromal cells in B.M. (except: Epo).
  • Generally, more than one GP needed to control hematopoietic.
  • React with specific membrane receptors.
  • Affect hematopoiesis directly or indirectly.
  • Act synergistically with each other.
  • The majority have multiple biologic activities (not lineage specific).
  • GP = Glycoprotein.

Early-Acting (Multilineage) GFs

  • Act on multipotential precursor cells. 
  • SCF, FL, IL-3, GM-CSF, IL-6 & IL-11
SCF:
  • SCF = Stem Cell Factor = Steel Factor “SF” = kit ligand “KL” = Mast Cell Growth Factor “MCGF” . 
  • Proliferation & differentiation of CFU-GEMM, CFU-GM, CFU-Mk, BFU-E. 
  • Also promotes the survival, proliferation & differentiation of mast cell precursors.
  • Plays role in normal melanocyte development & gametogenesis.
 Flt3 ligand (FL):
  • Increases recruitment of primitive HSC into the cell cycle & inhibits apoptosis.
  • Flt3 ligand has little effect on unilieage BFU-E/CFU-E, CFU-mast cell or CFU-Eo but it is a potent stimulator of granulocytic, B cell, & dendritic cell proliferation & differentiation.
  • HSC = Hematopoietic Stem Cell.
 IL-3

  • Affects multilineage progenitor cells & early commited progenitors like BFU-E.
  • Also has indirect actions & can can induce the expression of other cytokines.
GM-CSF

  • Affects CFU-GEMM, BFU-E, CFU-Mk, CFU-GM, & CFU-Eo. 
  • GM-CSF: it is a major promoter of granulocyte & monocyte differentiation, but lacks a significant effect on basophil production. 
  • GM-CSF also activates the functional activities of most nature phagocytes, including neutrophils, macrophages & eosinophils. 
IL-6 & IL-11:

  • They are pleiotropic cytokines with overlapping growth stimulatory effects on myeloid & lymphoid cells as well as on primitive multilineage cells. 
  • Significant effects on megakaryopoiesis & platelet production. 
  • Both also mediate the acute phase response of hepatocytes. Also they are major pyrogens in vivo. 
IL-11:


  • Shortens the duration of G0 of primitive hematopoietic progenitor cell & hastens hematopoietic recovery after treatment with cytotoxic agents or B.M. transplantation.

Later-Acting (Lineage-Restricted) GFs


  • G-CSF : granulocytes.  
  • M-CSF : monocytes. (Also regulates the genesis of osteoclasts).  
  • EPO : RBCs.  
  • TPO : megakaryocytes & platelets.  
  • IL-5 : eosinophils. (Also stimulates lymphocyte development).  
  • The other interleukins important in lymphopoiesis (ILs-2, -4, -7, -10, -12, -13, -14, -15).

Erythropoietin (EPO):

  • The only cytokine to function as true hormone. 
  • Embryonic life: produced largely by liver. 
  • Adult life: largely produced by kidney (~ 90%), & by liver (to a lesser extent; ~ 10%). 
  • Production is regulated by the oxygen needs; induced by hypoxia. 
  • Stimulates growth, survival, & differentiation of erythroid progenitor cells (major effect on CFU-E); & stimulates proliferation & RNA synthesis in more well-differentiated maturing cells. 
  • Reticulocytes & mature erythrocytes do not have receptors for EPO; so they are not affected by EPO.

Thrombopoietin (TPO):


  • TPO = mpl-ligand = megakaryocyte growth & development factor (MGDF). Megakaryocyte & platelet production.
  • In vitro, make/primes mature platelets to respond to aggregation-inducing stimuli & increases the platelet release reaction.
  • Act with a variety of other GFs (SCF, IL-3, FL) to stimulate the growth of primitive progenitor cell.

Indirect-Acting Growth Factors


  • Some cytokines that regulate hematopoiesis do so indirectly. 
  • Example: IL-1 . 
  • IL-1: has no colony-stimulating activity itself, but it induces neutrophilic leukocytosis, resulting from the release of other direct-acting cytokines by accessory cells. 


0 comments:

Post a Comment